Cathay Biotech Inc. (SHA:688065)
China
· Delayed Price · Currency is CNY 46.01
+0.58 (1.28%)
At close: Dec 5, 2025
Cathay Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 33,157 | 22,555 | 32,012 | 35,749 | 76,786 | 35,439 | Upgrade
|
| Market Cap Growth | 6.55% | -29.54% | -10.45% | -53.44% | 116.67% | - | Upgrade
|
| Enterprise Value | 28,047 | 22,818 | 31,823 | 33,878 | 71,142 | 29,114 | Upgrade
|
| Last Close Price | 46.01 | 38.48 | 54.26 | 60.32 | 128.99 | 59.08 | Upgrade
|
| PE Ratio | 50.14 | 46.13 | 87.34 | 64.61 | 129.11 | 77.43 | Upgrade
|
| Forward PE | 50.56 | 89.61 | 89.61 | 89.61 | 89.61 | 56.23 | Upgrade
|
| PS Ratio | 10.08 | 7.63 | 15.14 | 14.65 | 32.49 | 23.67 | Upgrade
|
| PB Ratio | 1.56 | 1.49 | 2.17 | 2.38 | 5.23 | 3.09 | Upgrade
|
| P/TBV Ratio | 1.96 | 2.08 | 3.06 | 3.52 | 7.77 | 3.49 | Upgrade
|
| P/OCF Ratio | 79.32 | 27.48 | 56.22 | 44.48 | 132.69 | 68.82 | Upgrade
|
| EV/Sales Ratio | 8.53 | 7.71 | 15.05 | 13.88 | 30.10 | 19.45 | Upgrade
|
| EV/EBITDA Ratio | 33.51 | 33.56 | 70.52 | 50.43 | 106.53 | 51.48 | Upgrade
|
| EV/EBIT Ratio | 56.27 | 62.70 | 192.23 | 83.32 | 142.50 | 65.10 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.13 | 0.12 | 0.08 | 0.05 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.33 | 2.79 | 3.94 | 1.68 | 1.11 | - | Upgrade
|
| Asset Turnover | 0.16 | 0.16 | 0.12 | 0.14 | 0.17 | 0.17 | Upgrade
|
| Inventory Turnover | 1.78 | 1.60 | 1.01 | 1.17 | 1.56 | 1.01 | Upgrade
|
| Quick Ratio | 5.86 | 1.99 | 1.70 | 4.75 | 8.14 | 16.89 | Upgrade
|
| Current Ratio | 6.94 | 2.53 | 2.22 | 5.95 | 9.36 | 19.42 | Upgrade
|
| Return on Equity (ROE) | 3.09% | 3.18% | 2.74% | 4.12% | 4.84% | 5.67% | Upgrade
|
| Return on Assets (ROA) | 1.52% | 1.20% | 0.56% | 1.49% | 2.20% | 3.08% | Upgrade
|
| Return on Capital (ROIC) | 1.68% | 1.36% | 0.63% | 1.61% | 2.32% | 3.40% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.30% | 2.30% | 1.10% | 2.50% | 3.30% | 3.80% | Upgrade
|
| Earnings Yield | 1.79% | 2.17% | 1.15% | 1.55% | 0.78% | 1.29% | Upgrade
|
| FCF Yield | -0.99% | -0.10% | -3.13% | -9.50% | -1.15% | -0.70% | Upgrade
|
| Dividend Yield | 0.87% | 1.04% | 0.35% | 0.30% | 0.25% | 0.97% | Upgrade
|
| Payout Ratio | 53.00% | 28.80% | 37.58% | 37.39% | 57.11% | 0.85% | Upgrade
|
| Buyback Yield / Dilution | -10.81% | -0.05% | 0.10% | 0.11% | -7.38% | -6.91% | Upgrade
|
| Total Shareholder Return | -9.93% | 0.99% | 0.45% | 0.41% | -7.13% | -5.94% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.